August 1, 2025 – Kleiner Perkins, a prominent venture capital firm, is having an excellent week, marked by significant returns from its investments in the Figma and Ambiq IPOs. The firm has seen impressive gains, further solidifying its position in the venture capital industry.
Figma’s IPO: A Huge Success for Kleiner Perkins
Figma, the design software company, made waves with its hot IPO earlier this week, opening at $33 per share and quickly climbing to new heights. Kleiner Perkins was a major backer of Figma, and its stake in the company has been particularly lucrative. The firm sold 1,346,499 shares of Figma at the IPO price, generating $91 million in returns.
However, Kleiner Perkins still holds a significant amount of Figma shares. According to company filings, Kleiner retains 52,364,374 shares, which, based on the closing price of $115 per share, is now valued at approximately $6.02 billion. This stake alone is worth three times the total capital Kleiner Perkins raised in its last mega-fund, which amounted to $2 billion across two vehicles in 2024.
The success of Figma’s IPO and the resulting increase in its stock price showcases the firm’s expertise in identifying high-potential investments, especially in the tech startup space. Kleiner Perkins partner Mamoon Hamid, who also serves on Figma’s board, was instrumental in overseeing this lucrative deal.
Ambiq IPO: Another Win for Kleiner Perkins
In addition to Figma, Kleiner Perkins also saw substantial returns from Ambiq Micro, a chip maker for wearable devices, which went public this week. Ambiq raised $96 million in its IPO by selling 4 million shares, with Kleiner Perkins holding 2,081,831 shares of the company. As of Friday, Ambiq shares were trading at $43.85, giving Kleiner Perkins a stake worth $91.3 million.
While Ambiq’s IPO was smaller than Figma’s, it still provides Kleiner Perkins with another strong investment in the growing tech market. Ambiq’s chips are used in wearables, an area seeing rapid growth due to increasing demand for smart devices and health tech solutions.
Looking Ahead: Motive Technologies IPO
Kleiner Perkins’ success doesn’t stop with Figma and Ambiq. The firm is also set to benefit from its investment in Motive Technologies, a fleet-tracking startup. Motive recently raised $150 million, and Kleiner Perkins led the funding round. Industry insiders are anticipating an IPO for Motive sometime in 2025, which could provide another major exit for the firm.
Conclusion: A Strong Track Record for Kleiner Perkins
Kleiner Perkins’ solid performance with Figma, Ambiq, and its other investments highlights its continued influence in the tech and venture capital sectors. The firm’s ability to back successful early-stage startups positions it well to capitalize on the ongoing growth of artificial intelligence, wearables, and other cutting-edge technologies.
As the firm looks ahead to more potential IPOs and exits, Kleiner Perkins’ track record remains a testament to its strategic investment approach and deep industry knowledge. The IPOs of Figma and Ambiq, along with other portfolio companies, underscore the strength of its position in the competitive venture capital landscape.
